News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Insider Information

Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics AG announces placement of maximal amount of convertible bonds

Epigenomics AG / Key word(s): Corporate Action 19.12.2013 09:40 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, December 19, 2013 – Epigenomics AG (ISIN: DE000A1K0516) announces the successful […]

Read more

Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics AG sets conversion price

Epigenomics AG / Key word(s): Corporate Action 13.12.2013 19:49 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics […]

Read more

Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics AG issues convertible bonds of up to EUR 2.68m

Epigenomics AG / Key word(s): Corporate Action 04.12.2013 01:09 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, December 3, 2013 – Epigenomics AG (ISIN: DE000A1K0516) announces that its […]

Read more

Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics AG Announces FDA Advisory Committee Meeting to Review Epi proColon(R)

Epigenomics AG / Key word(s): Miscellaneous 27.11.2013 16:30 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, November 27, 2013 – Epigenomics AG (ISIN: DE000A1K0516) announces that the Company […]

Read more

Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics AG issues EUR 500,000 in convertible bonds to Yorkville

Epigenomics AG / Key word(s): Corporate Action 06.11.2013 08:00 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, November 6, 2013 – Epigenomics AG (ISIN: DE000A1K0516, OTC: EPGNY) announces […]

Read more

Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Epigenomics AG successfully completes private placement of newly issued shares

Epigenomics AG / Key word(s): Capital Increase 29.10.2013 23:44 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Not for distribution in the United States Berlin, Germany, October 29, 2013 – […]

Read more